← all drugs
Oxaliplatin Injection
being discontinued · Oncology · Snapshot: 2026-10-09
- Manufacturers listed
- Fresenius Kabi USA, LLC, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Sandoz Inc.
- Machine-readable
- JSON for this drug
Presentations (6)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-20) | Fresenius Kabi USA, LLC | unknown | 02/25/2026 |
| Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-10) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | unknown | 06/29/2026 |
| Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-20) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | unknown | 06/29/2026 |
| Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3315-70) | Sandoz Inc. | unknown | 10/20/2025 |
| Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-10) | Fresenius Kabi USA, LLC | unknown | 02/25/2026 |
| Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3317-80) | Sandoz Inc. | unknown | 10/20/2025 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.